Mylotarg Recall: Cancer Drug Pulled Due to Health Risks, Low Benefits
The cancer drug Mylotarg is being pulled from the U.S. market after the FDA determined that it was ineffective and endangered patients’ health.
The cancer drug Mylotarg is being pulled from the U.S. market after the FDA determined that it was ineffective and endangered patients’ health.